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Abstract. 
 
The 
 
Drosophila myoblast city
 
 (
 
mbc
 
) locus 
was previously identified on the basis of a defect in myo-
blast fusion (Rushton et al., 1995. 
 
Development [Camb.].
 
 
121:1979–1988). We describe herein the isolation and 
characterization of the 
 
mbc
 
 gene. The 
 
mbc
 
 transcript 
and its encoded protein are expressed in a broad range 
of tissues, including somatic myoblasts, cardial cells, 
and visceral mesoderm. It is also expressed in the pole 
cells and in ectodermally derived tissues, including the 
epidermis. Consistent with this latter expression, 
 
mbc
 
 
mutant embryos exhibit defects in dorsal closure and 
cytoskeletal organization in the migrating epidermis. 
Both the mesodermal and ectodermal defects are remi-
niscent of those induced by altered forms of Drac1 and 
suggest that 
 
mbc
 
 may function in the same pathway. 
MBC bears striking homology to human DOCK180, 
which interacts with the SH2-SH3 adapter protein Crk 
and may play a role in signal transduction from focal 
adhesions. Taken together, these results suggest the 
possibility that MBC is an intermediate in a signal 
transduction pathway from the 
 
rho/rac
 
 family of GTP-
ases to events in the cytoskeleton and that this pathway 
may be used during myoblast fusion and dorsal closure.
 
I
 
n 
 
vertebrate organisms, a common feature of the myo-
genic differentiation program of all muscle fibers is
the apparent recognition, adherence, and fusion be-
tween myoblasts that generate multinucleate syncitia (for
review see Fischman, 1972; Wakelam, 1985). Since this
process can occur in cultured cells, tissue culture systems
have been invaluable in identifying regulators of myoblast
fusion. Essential components include cell adhesion mole-
cules, calcium and molecules that are regulated by it, me-
talloproteases, meltrins, lipids, and others (Yagami-Hiro-
masa et al., 1995; for reviews see Wakelam, 1985; Knudsen,
1991). Homologues to these vertebrate factors have not
yet been shown to function in myogenesis in 
 
Drosophila.
 
However, morphological studies have established that the
differentiated muscle fibers of insects are also syncitial
(Ball et al., 1985; Campos-Ortega and Hartenstein, 1985;
Bate, 1990, 1993; Doberstein et al., 1997). Therefore, one
might anticipate that similar molecules will control funda-
mental aspects of myoblast fusion in a variety of species.
Moreover, the use of genetics to identify critical myogenic
regulators and their relationship to other molecules in
 
Drosophila
 
 seems likely to reveal parallel pathways in ver-
tebrate organisms.
While it seems unlikely that all aspects of myogenesis
will be analogous between 
 
Drosophila
 
 and vertebrates,
many appear to be conserved between these organisms.
One example is the apparent conservation of myogenic
regulatory molecules. Among these are 
 
nautilus
 
 (Michel-
son et al., 1990; Paterson et al., 1991), which, like its verte-
brate counterparts (for review see Weintraub, 1993), can
induce a somatic muscle differentiation program (Keller et
al., 1997) and MEF2, an enhancer binding protein that is
absolutely required for the induction of muscle-specific
structural genes and myogenic differentiation (Lin et al.,
1996; for review see Olson et al., 1995). Similarities are
also apparent at the cellular level. For example, extensive
proliferation of myosin-expressing myoblasts is not ob-
served in either vertebrates (for review see Holtzer et al.,
1975
 
a
 
) or 
 
Drosophila
 
 (Campos-Ortega and Hartenstein,
1985; Bate, 1993; Rushton et al., 1995). In addition, al-
though fusion normally occurs before myosin expression
in vertebrate cells, it is not an absolute prerequisite for ex-
pression of myosin in either system (Holtzer et al., 1975
 
a
 
,
and references therein; see also Emerson and Beckner,
1975; Endo and Nadal-Ginard, 1987; Luo et al., 1994; Pau-
lulat et al., 1995; Rushton et al., 1995; Doberstein et al.,
1997). Finally, recent studies have revealed striking simi-
larities between the ultrastructure of fusing 
 
Drosophila
 
myoblasts (Doberstein et al., 1997) and fusing vertebrate
myoblasts (Engel et al., 1985; for review see Kalderon,
1980).
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The above studies suggest several parallels between
myogenesis in 
 
Drosophila
 
 and in vertebrate systems. How-
ever, little is actually known about the genes regulating
myoblast fusion in 
 
Drosophila
 
 and their mechanism of ac-
tion. Recently, several loss-of-function mutations that ex-
hibit defects in myoblast fusion have been identified, in-
cluding 
 
rolling stone
 
 (Paululat et al., 1995), 
 
myoblast city
 
(
 
mbc
 
)
 
1
 
 (Rushton et al., 1995), 
 
blown fuse
 
 (Doberstein et
al., 1997), 
 
sticks and stones
 
 (Abmayr, S.M., M.R. Erickson,
B.A. Bour, and M. Kulp. 
 
J. Cell. Biochem.
 
 1994. 18D
(Suppl.):474), and 
 
singles bar
 
 (Maeland, A.D., J.W. Bloor,
and N.H. Brown. 1996. 
 
Mol. Biol. Cell.
 
 7:39A). The pro-
tein coding sequence of 
 
blown fuse
 
, the first of these genes
to be identified, has not yet provided insight into its func-
tion. By comparison, examination of altered forms of the
small 
 
rho
 
-like GTPase, Drac1, has been useful in under-
standing myoblast fusion in 
 
Drosophila
 
 (Luo et al., 1994).
 
Drac1
 
 is the 
 
Drosophila
 
 homologue of the vertebrate gene
 
rac1
 
, which has been shown to induce membrane ruffling
through reorganization of the actin cytoskeleton (Ridley
et al., 1992). Both dominant negative and constitutively ac-
tive forms of Drac1 have been shown to cause defects in
myoblast fusion (Luo et al., 1994). Interestingly, altered
forms of Drac1 also disrupt the actin cytoskeleton in the
epidermis, causing defects in cell migration and dorsal clo-
sure (Harden et al., 1995), and in apical regions of the wing
imaginal disc (Eaton et al., 1995).
A role for the cytoskeleton in myoblast fusion in verte-
brates has previously been shown using low concentra-
tions of the inhibitor cytochalasin B, which interferes with
the formation of actin filaments. In these studies, the fu-
sion of myoblasts in culture was severely limited in the
presence of cytochalasin B, and most myotubes contained
only two nuclei (Sanger et al., 1971; Sanger and Holtzer,
1972). More recent studies have confirmed that both cy-
tochalasin B and D inhibit myoblast fusion and correlate
the lack of fusion with the disruption of actin filaments
(Constantin et al., 1995). While the role of the cytoskele-
ton at this early stage of myoblast fusion remains unclear,
it may be related to the formation of lipid-rich domains
within the cell membrane. Just before fusion, for example,
vertebrate myoblasts have been shown to undergo a topo-
logical change that results in the creation of protein-
depleted, lipid-enriched membrane domains (Kalderon
and Gilula, 1979; Fulton et al., 1981). These lipid-rich do-
mains are believed to be associated with an increase in
membrane fluidity (for review see Wakelam, 1985) and
may create sites for membrane–membrane fusion. Thus,
subcellular structures that organize these lipid-rich do-
mains may be dependent on cytoskeletal rearrangements.
Herein we describe the isolation and characterization of
the 
 
mbc
 
 gene. MBC is one of the first proteins identified in
 
Drosophila
 
 that is essential for myoblast fusion. It is ex-
pressed in a broad range of tissues throughout embryonic
development, including the presumptive musculature and
epidermal cells involved in the process of dorsal closure.
Consistent with its expression pattern, 
 
mbc
 
 mutant em-
bryos exhibit defects in dorsal closure and cytoskeletal or-
ganization as well as myoblast fusion. These abnormalities
 
are similar to those described above for the small GTPase
Drac1, and suggest that (
 
a
 
) 
 
mbc
 
 functions in the same
pathway as 
 
Drac1
 
 in the epidermis and (
 
b
 
) this pathway is
used in the mesoderm for events leading to myoblast fu-
sion. MBC has striking homology to DOCK180, a human
gene that was identified on the basis of interaction with
the small adapter protein Crk. DOCK180 may be involved
in signal transduction from focal adhesions, and results re-
ported herein are consistent with a similar function for
MBC. Finally, open reading frames (ORFs) from several
genome projects suggest that DOCK180 and MBC define
a new gene family.
 
Materials and Methods
 
Drosophila Stocks
 
All stocks were grown on standard cornmeal medium at 18 or 25
 
8
 
C, as
necessary. Balancer and marked chromosomes are described in FlyBase
(http://cbbridges.harvard.edu:7081). 
 
Df(3R)mbc-30
 
 has been described
(Rushton et al., 1995). 
 
Df(3R)mbc-15A
 
 was created by treating males ho-
mozygous for 
 
P{ry
 
1
 
, 
 
lacZ}
 
A189.2F3 (Bloomington Stock Center) with
4,000 rads of 
 
g
 
-rays. Approximately 25,000 chromosomes were screened
for the loss of the 
 
ry
 
1
 
 marker. Three deficiencies, including 
 
Df(3R)mbc-
15A
 
, were recovered.
 
Df(3R)CA15
 
 and 
 
Df(3R)CA2
 
 were obtained by imprecise excision of
the homozygous lethal P-element insertion 
 
l(3)04684
 
 (Bloomington Stock
Center, Bloomington, IN). Mobilization occurred in flies carrying
 
l(3)04684
 
 over 
 
Sb
 
, 
 
Delta2-3 ry
 
, and excision events were recovered over
MKRS or TM2. 677 excision events were analyzed. 330 imprecise excision
events were identified by lack of complementation of 
 
Df(3R)mbc-F5.3
 
/
TM3 (see Fig. 1). These were subsequently reevaluated for lack of com-
plementation of 
 
l(3)95BCd
 
 and 
 
l(3)01152
 
 and complementation of 
 
mbc
 
S4
 
.
Four deficiencies were obtained, two of which are shown in Fig. 1.
EMS mutageneses to obtain alleles of 
 
mbc
 
 have been described (Rush-
ton et al., 1995). In similar screens, 
 
z
 
11,000 additional chromosomes were
analyzed, and 14 new 
 
mbc
 
 alleles were obtained (Fig. 1). 
 
mbc
 
F5.3
 
 was later
found to be a small deletion. Additional mutations in this region identify
other lethal complementation groups. A subset of these are shown in Fig. 1.
 
Enriched DNA and Southern Analysis
 
DNA enriched for the mutant chromosomes was obtained by mating het-
erozygous (
 
mbc
 
/
 
1
 
) males and females, and collecting the homozygous
mutant embryos. Genomic DNA was prepared from unhatched embryos
according to Jowett (1986).
Approximately 10 
 
m
 
g of DNA was digested with EcoRI and BamHI,
separated on an 0.8% agarose gel, and blotted using the TurboBlotter
Rapid Downward Transfer System (Schleicher and Schuell, Inc., Keene,
NH). Blots were probed with various genomic fragments from region
95A-C and, as a control for loading, a 2-kb HindIII fragment that includes
exons 2, 3a, and 3b from the gene encoding myosin heavy chain (MHC)
(Wassenberg et al., 1987). All probes were labeled by random priming
(Feinberg and Vogelstein, 1983).
 
Library Screens, Northern Blots, and DNA Sequencing
 
Cosmids containing genomic DNA in cytological region 95A-C were ob-
tained from the European 
 
Drosophila
 
 Genome Project (EDGP). The P1
clone was isolated by the Berkeley 
 
Drosophila
 
 Genome Project (BDGP)
and provided by A. Spradling. Bacteriophage lambda clones were isolated
from a 
 
Drosophila
 
 genomic library in Charon 4 (Maniatis et al., 1978).
Fragments were subcloned and analyzed using Southern blots of DNA en-
riched for the deficiency chromosomes (see above). All DNA between the
distal breakpoint of 
 
Df(3R)CA15
 
 and the distal breakpoint of 
 
Df(3R)mbc-
15A
 
 was recovered. Genomic fragments containing coding sequence were
identified by probing Northern blots (Sambrook et al., 1989).
Subclones of genomic DNA that detected transcribed sequences were
used to screen an embryonic 9–12-h cDNA library (Zinn et al., 1988), and
several independent cDNA clones were obtained. These included Z5 (nu-
cleotides [nts] 1–2854), Z1.2 (nts 597–1928), Z10b (nts 4184–7040), and
 
1. 
 
Abbreviations used in this paper
 
: 
 
mbc
 
, 
 
myoblast city
 
; MHC, myosin
heavy chain; 
 
nau
 
, 
 
nautilus
 
; nts, nucleotides; ORF, open reading frame. 
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Z1.1 and Z6 (nts 6366–7376). DNA fragments from these phages were
subcloned into bacterial vectors and sequenced by the Penn State Nucleic
Acid Facility. Coding sequence not covered by cDNA clones was ob-
tained from cDNA primed from embryonic RNA and amplified by PCR.
In all cases, 
 
mbc
 
 coding sequence was determined from both DNA
strands.
 
Mutation Detection and Identification
 
Total RNA was prepared from 
 
mbc
 
/isogenic 
 
ru st e
 
 adults. cDNA was syn-
thesized with Superscript II (GIBCO BRL, Gaithersburg, MD) from vari-
ous 
 
mbc
 
-specific primers. Resulting cDNAs were used to localize muta-
tions within the 
 
mbc
 
 transcript using the Non-Isotopic RNase Cleavage
Assay (NIRCA) of the Mismatch Detect II
 
TM
 
 kit (Ambion, Inc., Austin,
TX). The mutation in allele 
 
mbc
 
F6.4
 
 was detected by a Southern blot of
heterozygous mutant DNA digested with EcoRI and BamHI, as described
above. The probe was a 6-kb genomic fragment corresponding to the mid-
dle of the transcript. Mutant sequences uncovered by either of these anal-
yses were analyzed in DNA enriched for the 
 
mbc
 
 alleles. Appropriate re-
gions were amplified by PCR and sequenced by the Penn State Nucleic
Acid Facility.
 
Analysis of Maternal and Adult mRNA
 
Total RNA was prepared from unfertilized eggs, adult males, and adult fe-
males (Jowett, 1986). cDNA was synthesized from a primer in the 3
 
9
 
 un-
translated region of the 
 
mbc
 
 gene, and the region between nucleotides
4563 and 5506 was amplified by PCR. Since this region of the 
 
mbc
 
 tran-
script spans an intron, contaminating genomic DNA does not give rise to a
 
PCR product. This result was confirmed by amplification of a second re-
gion between nucleotides 622 and 1515 (data not shown). To ensure that
approximately equal amounts of total RNA were present in each sample,
a Northern blot of the original RNA was probed with 
 
a
 
1-tubulin
 
 (Theur-
kauf et al., 1986) (data not shown).
 
Whole Mount Embryo Analysis
 
Embryos were collected on apple juice/agar plates for 0–6 h and aged as
necessary. The embryonic expression pattern of 
 
mbc
 
 mRNA was deter-
mined as described (Tautz and Pfeifle, 1989; Michelson et al., 1990) using
a digoxigenin-labeled cDNA fragment (nts 602–1922). 
 
mbc
 
-encoded pro-
tein was analyzed using a polyclonal rat antiserum (Cocalico Biologicals,
Reamstown, PA) that was directed against a 286–amino acid fusion pro-
tein. It included amino acids 1717–1970 from the COOH-terminal portion
of MBC and was purified from inclusion bodies. Before use, the antiserum
was affinity-purified against the original antigen coupled to Affigel 15
(BioRad Labs, Hercules, CA). For confocal studies, anti-MBC was used
at a dilution of 1:50, rabbit anti-MEF2 was used at 1:1,000 (Bour et al.,
1995), and monoclonal antiphosphotyrosine (Upstate Biotechnology, Inc.,
Lake Placid, NY) was used at a dilution of 1:100. For detection, fluores-
cein-conjugated goat anti–rabbit antiserum (Vector Laboratories, Burlin-
game, CA), fluorescein-conjugated goat anti–mouse antiserum (Rockland
Inc., Gilbertsville, PA), and CY-3–conjugated goat anti–rat antiserum
(Rockland Inc.) were used, as appropriate. All were preadsorbed over-
night on 0–12-h embryos before use. Colorimetric immunohistochemistry
used a monoclonal anti-MHC antibody (D. Keihart) at a dilution of 1:
2,000 and an anti–Fasciclin III monoclonal supernatant (Patel et al., 1987)
at a dilution of 1:10. These were detected with biotinylated antimouse an-
tiserum and the Vectastain ABC kit (Vector Laboratories). Where neces-
sary, balancer chromosomes were identified by 
 
b
 
-galactosidase activity
(Klambt et al., 1991) or by colorimetric immunohistochemistry using a
mouse monoclonal anti–
 
b
 
-galactosidase antibody (Promega Corp., Madi-
son, WI) at a dilution of 1:1,000. Staining with Texas red–conjugated phal-
loidin (Molecular Probes, Inc., Eugene, OR) was as described (Ash-
burner, 1989
 
b
 
). Four independent experiments were conducted. In two of
these studies, wild-type and mutant embryos were treated in parallel
throughout the entire analysis but kept in separate tubes. In two subse-
quent experiments, embryos from a wild-type stock and a balanced 
 
mbc
 
mutant stock were pooled. As in the first two experiments, balancer-con-
taining embryos from the mutant stock were identified using anti–
 
b
 
-galac-
tosidase. An average of 30 unstained embryos were mounted and ana-
lyzed in each experiment. The results of all four experiments gave
comparable results. In the phosphotyrosine experiments, a total of 30 em-
bryos were analyzed in two independent experiments carried out in paral-
lel in separate tubes.
 
Results
 
Genetic Localization of mbc
 
myoblast city
 
 was originally identified in a genetic analysis
of cytological region 95, on the right arm of the third chro-
mosome (Rushton et al., 1995). Since this is the location of
 
nautilus
 
 (
 
nau
 
), the 
 
Drosophila
 
 homologue of a conserved
family of myogenic regulatory genes (Michelson et al.,
1990; Paterson et al., 1991), it was of interest to examine
genetic lesions in this region for defects in myogenesis. Al-
leles of 
 
mbc
 
 were revealed in this analysis since embryos
mutant for 
 
mbc
 
 are characterized by an absence of differ-
entiated muscle fibers and the presence of a correspond-
ingly large number of unfused myoblasts (Rushton et al.,
1995). Overlapping deficiencies and EMS-induced point
mutations were therefore generated to refine the location
of 
 
mbc
 
 and establish that it represents a novel gene, inde-
pendent and separate from 
 
nau.
 
The current genetic map of this region is shown in Fig. 1.
 
Df(3R)mbc-30
 
 has been described (Rushton et al., 1995).
 
Df(3R)mbc-15A
 
 was generated by 
 
g
 
-irradiation of a
homozygous viable P-element insertion in this region.
Figure 1. Genetic and molecular map of cytological region 95BC.
(A) Deficiencies are represented by horizontal bars and lethal
complementation groups by vertical lines. Groups l(3)95BCa-d
have not been oriented with respect to each other. (B) Molecular
map of the region between the distal breakpoints of Df(3R)CA15
and Df(3R)mbc-15A, indicating P1, cosmid, and bacteriophage
lambda clones (gray lines). EcoRI sites are indicated. The loca-
tion of the mbc gene is indicated by a hatched bar, and the direc-
tion of transcription is marked by the arrow. (C) A Southern blot
of EcoRI/BamHI-digested DNA that was enriched for various
deficiency chromosomes, including isogenic ru st e and mbcF6.4 as
controls. The test probe is a 2.8-kb EcoRI fragment from P1
clone DS07442 (upper band) while the control probe is a frag-
ment from MHC (lower band).The Journal of Cell Biology, Volume 138, 1997 592Erickson et al. Cloning and Characterization of myoblast city 593
Figure 2. MBC sequence and alignment with human DOCK180 as well as related open reading frames. The alignment was done using
Clustal W and presented using Boxshade. Black boxes indicate amino acid identity, while gray boxes indicate amino acid similarity to
MBC. Arrowheads highlight mutations found in mbc alleles. The consensus Crk-binding sites (PPxLPxK) of DOCK180 are underlined.
A potential Crk-binding site in MBC is noted with dots. Stars mark essential SH3 consensus residues (Musacchio et al., 1994). The Gen-
Bank/EMBL/DDBJ accession numbers are D86964 for the myeloblast-specific cDNA KIAA0209, Z81032 and Z81054 for the C. ele-
gans ORFs, and AA110899 for the mouse expressed sequence tag. mbc sequence data are available from GenBank/EMBL/DDBJ under
accession number AF007805.The Journal of Cell Biology, Volume 138, 1997 594
Df(3R)CA15 and Df(3R)CA2 were isolated by imprecise
excision of l(3)04684, a homozygous-lethal P-element in-
sertion. Df(3R)CA15 deletes from the P-element insertion
toward the distal end of the chromosome. In contrast,
Df(3R)CA2 deletes from the P-element toward the cen-
tromere. These deficiencies have been examined for the
presence or absence of nau sequences by Southern analy-
sis of DNA from embryos homozygous for the deficien-
cies. By comparison to Df(3R)mbc-30 and Df(3R)mbc-
15A, which completely remove nau, neither Df(3R)CA15
nor Df(3R)CA2 appear to remove any known nau se-
quences (data not shown). Consistent with this genetic
map, recent results have established that nau is located in
the region centromeric to the proximal breakpoint of
Df(3R)CA2 (Keller, C.A., and S.M. Abmayr, unpublished
results).  Df(3R)mbc-F5.3 actually represents an EMS-
induced deletion. It does not complement mbc, as shown
in Fig. 1, but contains all known nau sequences (data not
shown). Finally, EMS-induced point mutations reveal sev-
eral additional complementation groups in this region.
Other than the transposable element insert TnM2, only
those groups distal to the Df(3R)CA2 breakpoint are
shown in Fig. 1.
These deficiencies refined the location of mbc to the re-
gion between the distal breakpoint of Df(3R)CA15 and
the distal breakpoint of Df(3R)mbc-15A and facilitated
the cloning of the mbc gene. Of note, several attempts to
isolate a P-element insertion in mbc were unsuccessful
(data not shown). Therefore, a molecular walk through
this region was initiated using DNA fragments isolated
from P1 clones and cosmids that have been mapped to re-
gion 95BC. Fragments within this genetic interval were
identified by Southern analysis of DNA from embryos ho-
mozygous for the various deficiency chromosomes. A rep-
resentative example is shown in Fig. 1 C. The entire region
between these deficiency breakpoints is diagrammed in
Fig. 1 B and spans z34 kb of DNA. As indicated, the orga-
nization of these fragments has been confirmed by isola-
tion of bacteriophage lambda clones containing Drosoph-
ila genomic DNA.
Identification of the mbc Gene
A single full-length transcript of z7.5 kb was detected by
Northern analysis throughout development using cloned
DNA fragments within the 34-kb region described above.
Although full-length clones were not obtained, several
small overlapping cDNA clones provided most of the cod-
ing sequence of this transcript. The sequence of a small re-
gion not covered in the cDNA clones was obtained from
embryonic mRNA by reverse transcriptase PCR amplifi-
cation and sequencing. The embryonic transcript is z7.4
kb, with a coding sequence of 5,910 nts. Untranslated re-
gions at the 59 and 39 ends of the isolated cDNAs are 560
and 906 bp, respectively. While the genomic organization
of mbc has not been analyzed completely, a minimum of
eight introns have been identified in a genomic region that
spans at least 16 kb. The cDNA sequence has been submit-
ted to GenBank and is not reproduced herein. The de-
duced amino acid sequence is shown in Fig. 2.
To confirm that this transcript encodes the mbc gene,
EMS-induced alleles of mbc were analyzed for sequence
alterations. To date, 18 independent alleles of mbc have
been generated. Four of these have been described previ-
ously (Rushton et al., 1995), while the remaining 14 were
generated as part of this analysis. Southern analysis of all
alleles was performed to reveal visible rearrangements in-
duced by the chemical mutagen. This analysis uncovered a
novel band in an EcoRI/BamHI double digest of DNA
from mbcF6.4 (data not shown). Sequence analysis con-
firmed that the BamHI site had been destroyed by a C to
T transition. This missense mutation at amino acid 1579 of
the coding sequence changes a proline to a leucine in a
conserved region of the protein (Fig. 2, arrowhead).
Additional aberrations were uncovered using a proce-
dure for detecting point mutations that is based on the
ability of RNase A to cleave at single base pair mis-
matches. Several regions of the coding sequence were ana-
lyzed by this method and apparent alterations in the candi-
date sequence were found in three EMS-induced mbc
alleles (data not shown). Direct sequencing of these alleles
revealed that all were GC to AT transitions at single nu-
cleotides, consistent with the most common form of EMS-
induced mutations (Ashburner, 1989a). These changes re-
sulted in nonsense mutations at amino acid 492 in mbcF12.7
and at amino acid 97 in mbcD11.2. By comparison, mbcI6.6 is
a missense mutation at amino acid 168 where a glycine has
been replaced by a glutamic acid (Fig. 2).
Structural Homologues of MBC
The size of the mbc-encoded protein is 1,970 amino acids,
with a predicted molecular mass of about 226 kD. Data-
base homology comparisons using BLAST (Altschul et al.,
1990) aligned the MBC protein with DOCK180, a human
protein of 1,866 amino acids, with a predicted molecular
mass of 215 kD (Hasegawa et al., 1996). DOCK180 was
isolated on the basis of an interaction with Crk, a small
adapter protein consisting mainly of SH2 and SH3 do-
mains (Reichman et al., 1992; see Discussion). MBC and
DOCK180 have significant homology throughout their en-
tire length. In particular, DOCK180 contains a putative
SH3 domain that proceeds from amino acids 11–71 and in-
cludes the three essential SH3 consensus residues (Musac-
chio et al., 1994). These three residues, along with several
others within this domain, are identical in MBC. DOCK180
contains two copies of the Crk-binding consensus site PPx-
LPxK (Knudsen et al., 1994; Matsuda et al., 1996), while
MBC has one exact and one slightly divergent copy of this
consensus site (Fig. 2). By contrast, the putative ATP-
binding site noted by Hasegawa et al. (1996) is not con-
served. Several additional blocks of homology are present,
notably a region in which 24 of 27 amino acids are identi-
cal (residues 1566–1592 of MBC). A lesion in the central
proline of this block, identified above in mbcF6.4, resulted
in a mutant phenotype identical to that previously de-
scribed (Rushton et al., 1995). This apparent loss-of-func-
tion phenotype is identical to that found in alleles with a
severely truncated protein (e.g., mbcD11.2; data not shown).
Subsequent BLAST searches also revealed two ORFs
with extensive homology to MBC and DOCK180. The
first ORF is from a human myeloid cell line, and the sec-
ond is from the Caenorhabditis elegans genome project.
The predicted myeloblast protein is highly homologous toErickson et al. Cloning and Characterization of myoblast city 595
both MBC and DOCK180, while the predicted C. elegans
protein is more divergent. Partial sequence from a mouse
expressed sequence tag suggests the existence of a murine
homologue as well.
Temporal Expression of mbc
Northern analysis revealed that mbc is expressed early in
development, in embryos z0–4 h after egg laying. mbc
transcript levels remain relatively high during embryogen-
esis, with the possible exception of a decline from 8–12 h
that may be, in part, an artifact of slightly degraded
mRNA (Fig. 3 A). Expression was not evident during lar-
val stages, but the transcript does reappear during pupa-
tion, suggesting a possible role in adult development. A
form of mbc with slightly altered mobility appears late in
metamorphosis. This transcript may reflect alternative
splicing and is under further investigation (Fig. 3 A, lane
9). PCR amplification of two different regions from the
mRNA of unfertilized embryos revealed a small but de-
tectable signal, and suggested that the transcript is mater-
nally provided. Finally, the transcript was expressed in
adult males and females, as evidenced by PCR analysis of
cDNA (Fig. 3 B).
Spatial Expression Pattern of mbc mRNA and Protein 
during Embryogenesis
The earliest expression of the mbc transcript is in the pole
Figure 3. Temporal expression of the mbc transcript. (A) A
Northern blot containing 4 mg of poly A1 RNA from several
stages of development. Probes included a 1.8-kb genomic EcoRI
fragment that includes mbc coding sequence and a 400-bp Xba/
HindIII fragment of a1-tubulin (Theurkauf et al., 1986) as a con-
trol for loading. (B) Reverse transcriptase PCR analysis of mbc
RNA from unfertilized embryos. 0–4-h embryos, adult females,
and adult males as detailed in Materials and Methods.
Figure 4. Spatial expression pattern of mbc mRNA in wild-type embryos. In all panels, anterior is to the left. In A, D, E, F, and G, dorsal
is at the top. (A) Lateral view, early stage 4, before cellularization. (B) Dorsal view, stage 5. (C) Ventral view, stage 6; the invaginating
ventral furrow is evident. (D) Lateral view, stage 9. (E) Lateral view of the ectoderm, late stage 12; arrows highlight ectodermal stripes.
(F) Lateral view focusing on the mesoderm and endoderm of the same embryo as in E. (G) Lateral view, stage 14; focusing on mesoder-
mal cells. (H) Dorsal view, stage 14; arrowheads indicate the visceral musculature. (I) Dorsal view; stage 16; expression is evident in the
cardial and pericardial cells of the dorsal vessel.The Journal of Cell Biology, Volume 138, 1997 596
cells (Fig. 4 A). It is later found in lateral portions of the
embryo during cellularization (Fig. 4 B) but is not evident
at the termini. Surprisingly, the ventral furrow, which will
invaginate during gastrulation to form the mesoderm,
shows no expression at this time (Fig. 4 C). At germband
elongation, expression is still quite strong in the ectoderm
(Fig. 4 D). By late stage 12, the mRNA appears to be de-
creasing in the ectoderm, leaving a pattern of stripes (Fig.
4 E, arrows). mbc is expressed in both the mesoderm and
endoderm during stage 12 (Fig. 4 F). Expression decreases
in both the epidermal layer and the somatic mesoderm
during stage 14 (Fig. 4 G) but remains strong in the vis-
Figure 5. Spatial expression pattern of MBC in wild-type embryos. Anterior is to the left and dorsal to the top in all except A. (A) Stage
13 embryos from the progeny of mbcD11.2/TM3 lacZ-hg stained immunohistochemically for MBC. The embryo to the top left expressed
b-galactosidase and therefore carried TM3 lacZ-hg; the embryo to the bottom right (which is barely visible) did not express b-galactosi-
dase (data not shown) and was therefore homozygous for mbcD11.2. As anticipated, no MBC expression is visible in the homozygous mu-
tant embryo, establishing specificity of the antiserum. (B) Wild-type; Lateral view, stage 5. (C) Wild-type; Lateral view, stage 8. (D)
Wild-type; Lateral view, stage 14; arrow indicates the visceral musculature (vm). (E and F) Wild-type; Lateral views, stage 16; arrows in
E highlight somatic muscles 8, 12, and 19, using the nomenclature of Crossley (1978). Arrow in F marks the dorsal vessel (dv). Bars: (A–
D and F) 100 mm; (E) 10 mm.Erickson et al. Cloning and Characterization of myoblast city 597
ceral musculature (Fig. 4 H, arrowheads). Examination of
a stage 16 embryo revealed mRNA in both the cardial and
pericardial cells of the dorsal vessel (Fig. 4 I). Of note, the
mbc transcript is not observed in mature muscle fibers.
The expression pattern of MBC was analyzed by fluo-
rescent immunohistochemistry and confocal microscopy
using an antiserum directed against the COOH-terminal
portion of the protein. Examination of embryos homozy-
gous for mbcD11.2 confirmed that the antiserum was specific
(Fig. 5 A) since this allele encodes a severely truncated form
of MBC that would not be detected. While slight temporal
differences were evident between maximal levels of
mRNA (stage 4; Fig. 4 A) and maximal levels of protein
(stage 5; Fig. 5 B) in the pole cells, the expression of the
protein essentially correlated with that of the mRNA.
MBC appeared to be localized in the cytoplasm (Fig. 5 C),
consistent with its human counterpart DOCK180. MBC is
also present in the visceral musculature (Fig. 5 D, arrow)
and the dorsal vessel (Fig. 5 F, arrow). Cross reactivity of
the MBC antiserum was observed in the filtzkorper (Fig. 5
F) but does not correlate with the presence of transcript.
Although mRNA was not evident in mature muscles, the
protein could be detected at a low level (Fig. 5 E).
Fluorescent immunohistochemistry and confocal mi-
croscopy were used to confirm that MBC is present in myo-
blasts. For this analysis, the embryos were hybridized with
antibodies to both MBC and MEF2. The mef2 gene en-
codes a transcription factor that appears to be expressed
throughout the mesoderm, including somatic muscle pre-
cursors and all muscle fibers (for review see Olson et al.,
1995). Nuclei expressing MEF2 were visualized in a late
stage 12 embryo in green (Fig. 6 C). By comparison, cyto-
plasmic expression of MBC was visualized in red (Fig. 6
A). As anticipated from the expression pattern of mRNA,
MBC is present in ectodermal and endodermal germ lay-
ers. Of note, expression in the ectoderm is concentrated in
the epidermal layer and appears to be absent from the un-
derlying neuroectoderm. MBC is also clearly present in
presumptive myoblasts, coincident with the MEF2-express-
ing nuclei (Fig. 6 B).
Examination of Mesodermal Derivatives in mbc
Mutant Embryos
Given the broad expression pattern of mbc, it was of inter-
est to examine mbc mutant embryos for defects in other
tissues. For this purpose we used mbcF12.7, since the pro-
tein is truncated at amino acid 492, and analyzed embryos
that were genetically mbcF12.7/Df(3R)mbc-30. These em-
bryos exhibited the severe somatic muscle phenotype pre-
viously reported (Rushton et al., 1995) and shown in Fig. 7
B. By comparison, although the visceral musculature ap-
peared to be present, as evidenced by myosin-staining
cells, obvious defects in midgut constriction and orienta-
tion were observed in z25% of the embryos (Fig. 7, C and
D). However, these defects may be an indirect conse-
quence of the lack of somatic muscles rather than a direct
effect of the loss of MBC in either the visceral mesoderm
or the endoderm. The overall structure of the heart, which
expresses MBC late in development, appeared to be nor-
mal at this level of analysis (Fig. 7, E and F).
Examination of Dorsal Closure and Cytoskeletal 
Organization in the Epidermis
Although no epidermal defects had been reported in mbc
mutant embryos (Rushton et al., 1995), the early expres-
Figure 6. Colocalization of MBC with MEF2 in myoblasts. Using
fluorescent immunohistochemistry and confocal microscopy, em-
bryos were analyzed for expression of MBC (red) and MEF-2
(green). The posterior end of an embryo late in stage 12 that is
oriented anterior to the left and dorsal to the top is shown. (A)
MBC expression. Arrows indicate the posterior midgut primor-
dium (pm) and the epidermis (ep). (B) A composite of A and C,
illustrating colocalization in the somatic mesoderm (sm) and the
visceral mesoderm (vm). (C) MEF-2 expression. Bar, 50 mm.The Journal of Cell Biology, Volume 138, 1997 598
sion of mbc in the ectoderm, which persists in the epider-
mis into stage 14, led us to reexamine mbc mutant em-
bryos for epidermal defects. Visualization of the epidermis
with an antibody to Fasciclin III, a glycoprotein on the cell
surface (Patel et al., 1987), revealed defects in dorsal clo-
sure in z80% of the mutant embryos (Fig. 8, E and F).
The extent of completion of dorsal closure varied from a
relatively small opening surrounded by puckered mis-
shapen cells (data not shown) to a very large opening (Fig.
8 E). In the normal course of dorsal closure in a wild-type
embryo, the epidermal cells elongate as shown in Fig. 8 B,
and the epithelium stretches over the entire circumference
of the embryo (Young et al., 1993). In the early stages of
dorsal closure in mbc mutant embryos, the cells along the
leading edge of the epidermis appeared to be normal (data
not shown). As dorsal closure neared completion, how-
ever, many cells along the leading edge ceased to be elon-
gated, adopted a rounded shape, and expressed Fasciclin
III abnormally along their migrating edge (Fig. 8, B, D,
and F).
The cytoskeleton along the leading edge of the epider-
mis has been implicated in driving the process of dorsal
closure (Young et al., 1993). We therefore used fluores-
cently conjugated phalloidin, which binds filamentous ac-
tin, to examine the mbc mutants for defects in cytoskeletal
formation and organization. Both wild-type and mbc mu-
tant embryos displayed some variability in the intensity
and organization of staining, the range of which is shown
in Fig. 9. As shown, the signal in wild-type embryos (Fig. 9
A, a and c) was always stronger than that in mbc mutant
embryos (Fig. 9 A, b and d). While frequently more dra-
matic in cells along the migrating edge, this reduction in
signal was also observed throughout the epidermis, consis-
tent with the observed expression of mbc. In addition, it
should be noted that z20% of the mbc mutant embryos
do not exhibit defects in dorsal closure (mentioned above).
One might anticipate that these embryos would express
relatively normal levels of filamentous actin and exhibit
only mild cytoskeletal defects, such as that shown in Fig. 9
A, b. In summary, this analysis suggests that there is a
modest but reproducible reduction in cytoskeletal organi-
zation in the epidermis of mbc mutant embryos. Unfortu-
nately, examination of the cytoskeletal structure in muscle
cells was complicated by the dynamic nature of wild-type
muscle cells, making rigorous comparisons with compara-
ble muscle cells in mbc mutant embryos difficult.
Figure 7. Analysis of mesodermal derivatives in mbc mutant embryos. Tissues were visualized with a monoclonal antibody to MHC. All
embryos are oriented with anterior to the left. A and B are lateral views with dorsal to the top, C and D are ventral views, and E and F
are dorsal views. A, C, and E are wild-type embryos; B, D, and F are mbcF12.7/Df(3R)mbc-30 transheterozygotes. (A and B) Somatic
muscle pattern of stage 16 embryos. Defects in myoblast fusion, as previously described by Rushton et al. (1995), are evident in B. (C
and D) Visceral musculature and gut formation in late stage 16 embryos. Note the midgut constrictions in C and the absence of these
constrictions in D. (E and F) Dorsal vessel of stage 17 embryos. At this level, there are no obvious defects. Bars, 50 mm.Erickson et al. Cloning and Characterization of myoblast city 599
DOCK180, the apparent human homologue of mbc,
may be involved in Crk-associated signal transduction
from focal adhesions (Hasegawa et al., 1996). If mbc func-
tions in a similar signal transduction pathway in Drosoph-
ila, we anticipated that it would be downstream of focal
adhesions. Examination of putative focal adhesions in the
epidermis of mbc mutant embryos was accomplished using
a monoclonal antibody directed against phosphotyrosine,
as previously described (Maher et al., 1985; Hanks et al.,
1992; Harden et al., 1996). In contrast to the cytoskeletal
defects described above, comparison of phosphotyrosine
staining patterns in the epidermis of wild-type embryos
and homozygous mbcD11.2 embryos revealed no apparent
difference during dorsal closure (Fig. 9 B, a and b). This
observation is consistent with the possibility that MBC,
like DOCK180, is downstream of phosphotyrosine-con-
taining complexes in a signal transduction pathway that, in
Drosophila, ultimately affects cell migration, dorsal clo-
sure, cytoskeletal organization, and myoblast fusion.
Discussion
The results reported here describe the cloning and charac-
terization of myoblast city, a gene that was initially identi-
fied on the basis of a defect in myoblast fusion (Rushton et
al., 1995). mbc encodes a novel Drosophila protein with a
high degree of homology to the human Crk-associated
protein, DOCK180 (Hasegawa et al., 1996). Consistent
with that of its human counterpart, mbc expression is not
restricted to the somatic mesoderm. Early in development,
expression is observed in the pole cells and ectoderm but
is absent from the mesodermal epithelium. Later in devel-
opment, expression is most evident in the epidermis and
mesoderm but is absent from neural tissues. The latest de-
tectable expression is in mesodermal derivatives that in-
clude the heart and visceral musculature. Consistent with
this pattern of expression, defects in myoblast fusion are
accompanied by abnormalities in the midgut constrictions
and in the ability of the epidermal cells to complete dorsal
closure. These cells exhibit alterations in shape, migration,
and deposition of Fasciclin III, as well as cytoskeletal orga-
nization. Previous studies have reported similar defects for
Drac1 (Luo et al., 1994; Harden et al., 1995), the Drosoph-
ila homologue of the small GTPase rac1, and imply that
mbc may function in the same pathway. Finally, ORFs
identified from multiple genome sequencing projects may
indicate that MBC and DOCK180 are members of a
highly conserved gene family.
The Role of mbc in Ectodermally Derived Tissues
Early expression of mbc in the ectoderm and its persis-
tence in the epidermis led us to examine mbc mutant em-
bryos for epidermal defects. Using Fasciclin III as a marker,
we observed that mbc mutant embryos were unable to
complete the process of dorsal closure. Contractile fila-
ments formed from actin and myosin are thought to pro-
vide the driving force for dorsal closure. Consistent with
this suggestion, the absence of nonmuscle myosin in zipper
Figure 8. Defects in dorsal closure in
mbc mutants revealed by staining with
Fasciclin III. All panels are dorsal views
with anterior to the left. A–D are wild-
type embryos while E and F are mbcF12.7/
Df(3R)mbc-30 transheterozygotes. A
and  B  show a stage 15 embryo in the
process of dorsal closure. Arrow in B de-
notes elongated cells at the leading edge.
C and D show a stage 16 embryo that has
completed dorsal closure. E and F show
a stage 16 embryo that has a pronounced
defect in dorsal closure. Arrow denotes
cells that are misshapen and have an im-
proper accumulation of Fasciclin III
along the leading edge. Bars: (A, C, and
E) 50 mm; (B, D, and F) 25 mm.The Journal of Cell Biology, Volume 138, 1997 600
mutant embryos is likely to be responsible for their failure
to complete this process (Young et al., 1993). Similarly,
overexpression of a form of Drac1 that disrupts both actin
and nonmuscle myosin accumulation at the leading edge
of the migrating epidermis also inhibits dorsal closure
(Harden et al., 1995). Finally, the dorsal closure defects
observed in mbc mutants are accompanied by reduced de-
tection of filamentous actin. These results implicate mbc in
cytoskeletal organization and dorsal closure and suggest
that it may function in the same pathway as Drac1.
Recent studies have shown that Drac1 is necessary for
the presence of phosphotyrosine-containing complexes at
the leading edge of the epidermis that have been sug-
gested as focal adhesions (Harden et al., 1996). The rho/
rac family of small GTPases has also been implicated in
the formation of focal adhesions and in the organization of
the actin cytoskeleton in vertebrates (Ridley and Hall,
1992, 1994; Ridley et al., 1992; Nobes and Hall, 1995;
Chrzanowska-Wodnicka and Burridge, 1996; for reviews
see Clark and Brugge, 1995; Richardson and Parsons,
1995; Takai et al., 1995). The loss of mbc does not appear
to affect the formation of these phosphotyrosine-contain-
ing complexes, implying that mbc may function down-
stream of Drac1. This interpretation is consistent with one
possible role of human DOCK180 in mediating a signal
from focal adhesions to downstream effectors (Hasegawa
et al., 1996). Specifically, DOCK180 was isolated on the
basis of interaction with the small SH2-SH3 domain-con-
taining adapter protein, Crk (Reichman et al., 1992). Stud-
ies addressing the roles of both c-Crk and its oncogenic
counterpart v-Crk have suggested an involvement in signal
transduction pathways that include receptor tyrosine ki-
nases, ras and MAP kinase, and focal adhesions (Tanaka
et al., 1993; Feller et al., 1994; Hempstead et al., 1994; Mat-
suda et al., 1994; Schaller and Parsons, 1994; Clark and
Brugge, 1995; Richardson and Parsons, 1995; Hanks and
Polte, 1997). Recently, several proteins have been identi-
fied on the basis of interaction with Crk and are likely to
Figure 9. Accumulation of filamentous actin and phosphotyrosine in the epidermis of mbc mutant embryos. Confocal micrographs of
embryos stained with Texas red–conjugated phalloidin (A) or an antiphosphotyrosine antibody (B). Anterior is to the left in all panels.
A, a and c, and B, a show stage 14 wild-type embryos. A, b and d, and B, b show stage 14 mbcD11.2 homozygous embryos. Bar, 10 mm.Erickson et al. Cloning and Characterization of myoblast city 601
be downstream effectors. Among these is the guanine nu-
cleotide exchange factor C3G (Tanaka et al., 1994). Crk
may be a critical mediator of signal transduction to events
in the nucleus through these molecules. In addition, bio-
chemical evidence has shown that v-Crk and c-Crk can in-
teract with phosphorylated paxillin (Birge et al., 1993;
Schaller and Parsons, 1995), one of the components of the
focal adhesion (Turner et al., 1990).
It should be noted that although both mbc loss-of-func-
tion and dominant negative Drac1N17 embryos exhibit sim-
ilar defects in dorsal closure and cytoskeletal organization
in the epidermis and fusion of myoblasts in the mesoderm
(see below), Drac1N17 also induces defects in the periph-
eral nervous system. In contrast, both the motor neurons
and the peripheral nervous system of mbc mutant embryos
appear to be normal (Rushton et al., 1995; Prokop et al.,
1996; Erickson, M.R.S., and S.M. Abmayr, unpublished
observation), consistent with the minimal level of MBC
expressed in neural tissues. The simplest interpretation of
this apparent inconsistency is that particular factors medi-
ate different aspects of the Drac1 signal transduction cas-
cade. In support of this hypothesis, several different mole-
cules have been identified on the basis of an interaction
with vertebrate Crk (Feller et al., 1995, and references
therein).
The Role of mbc in Myoblast Fusion
The most apparent mesodermal defect in embryos mutant
for the mbc gene is an inability of myoblasts to fuse into
muscle fibers, suggesting a role for mbc in the progression
of cells from myoblasts to myotubes. This multistep pro-
cess has been divided into several stages (Knudsen and
Horwitz, 1977, 1978; for reviews see Bischoff, 1978;
Wakelam, 1985) and includes the acquisition of fusion
competence, a time-dependent behavior that may be re-
lated to withdrawal from the cell cycle (Bischoff and
Holtzer, 1969; Yaffe, 1971; Holtzer et al., 1975b), myoblast
adhesion, and plasma membrane union.
Several features of the mbc-encoded protein seem
somewhat inconsistent with a role in either cell adhesion
or membrane fusion itself. First, MBC does not have fea-
tures reminiscent of cell adhesion molecules and appears
to be present throughout the cytoplasm rather than mem-
brane bound. Second, both MBC and its structural homo-
logue, DOCK180 (Hasegawa et al., 1996), are expressed in
a wide range of tissues that do not fuse. The potential con-
servation of MBC and DOCK180 in C. elegans, in which
the muscle fibers remain mononucleate (Waterston, 1988),
is also inconsistent with a direct role for mbc in the fusion
process. An alternative possibility is that mbc functions in
myoblast differentiation. As mentioned earlier, DOCK180
was identified and subsequently isolated on the basis of in-
teraction with the adapter protein Crk (Reichman et al.,
1992). Studies addressing the roles of both c-Crk and
v-Crk have implicated these molecules in cell differentia-
tion (Tanaka et al., 1993; Hempstead et al., 1994). Thus,
mbc may be essential for a cytoskeleton-related step in dif-
ferentiation through which, among other things, myoblasts
become competent to fuse.
We favor the interpretation that the function of MBC in
the mesoderm is analogous to its role in the epidermis and
that it functions as an essential intermediate in a signal
transduction cascade that also includes the small GTPase
Drac1. This pathway could involve tyrosine phosphoryla-
tion of complexes that directly modulate events in the cy-
toskeleton through proteins that include MBC. Alterna-
tively, MBC may function in signal transduction to the
nucleus via the ras and MAP kinase pathway and may af-
fect the cytoskeleton only indirectly. Interestingly, while
vertebrate studies have not revealed a specific require-
ment for focal adhesions in myogenesis, they have impli-
cated extracellular matrix components that stimulate focal
adhesions, such as fibronectin, in myogenic differentiation
(Chen, 1977; Furcht et al., 1978; Menko and Boettiger,
1987; Guan and Shalloway, 1992; Hanks et al., 1992;
Enomoto et al., 1993). Additional studies in vertebrates
support a role for the cytoskeleton in myoblast fusion. As
previously described (see introduction), myoblast fusion is
severely limited in the presence of cytochalasin B, an alka-
loid that interferes with the assembly of actin filaments
(Sanger et al., 1971; Sanger and Holtzer, 1972). While the
role of the cytoskeleton in myoblast fusion remains un-
clear, it may be involved in the formation of lipid-rich do-
mains within the cell membrane that create sites for mem-
brane–membrane fusion. Alternatively, actin filaments
may be required for the formation or organization of vesi-
cles that have been observed under the plasma membrane
just before fusion of both vertebrate and Drosophila myo-
blasts (Doberstein et al., 1997; for review see Kalderon,
1980). Interestingly, these vesicles are not observed in mbc
mutant embryos, perhaps as a consequence of defects in
the actin cytoskeleton (Doberstein et al., 1997).
Additional studies will be necessary to resolve the exact
role of mbc in myoblast fusion. In particular, whereas focal
adhesions in vertebrates are generally thought to mediate
interactions between the cell and the extracellular matrix,
no cell–matrix interactions have yet been identified in the
Drosophila mesoderm (Tepass and Hartenstein, 1994). In
addition, on the basis of examination of phosphotyrosine-
containing complexes, our studies seem most consistent
with a role for mbc downstream of Drac1 in the epidermis.
By comparison, Doberstein et al. (1997) place mbc up-
stream of a constitutively active form of Drac1. As dis-
cussed by these authors, however, the analysis of Drac1 is
presently limited to targeted expression of altered forms
of the protein and is problematic in the absence of a loss-
of-function mutation. It may also reflect a second role for
Drac1 in myoblast fusion, not inconsistent with the sugges-
tion that GTPases may act downstream of focal adhesions
(Schaller and Parsons, 1994; Clark and Brugge, 1995;
Hanks and Polte, 1997). One intriguing possibility consis-
tent with our data and that of Doberstein et al. (1997) is an
early requirement for activated Drac1, perhaps to facili-
tate recruitment of paired vesicles to the membrane via
the cytoskeleton, followed by an equally important re-
quirement for Drac1 inactivation later, before fusion. One
final issue is that genetic studies have not yet revealed a
role for integrin subunits, one of the major components of
vertebrate focal adhesions, in myoblast fusion. The lar-
val body wall muscles in embryos mutant for the major in-
tegrin subunits, bPS, aPS1, and aPS2, do not appear to ex-
hibit defects in fusion (Brown, 1994; Roote and Zusman,
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However, the number and alternatively spliced forms of
integrins identified in Drosophila has continued to in-
crease (Gotwals et al., 1994), and family members that
play other roles in myogenesis may yet be isolated. Thus,
greater knowledge of GTPases and integrins and the iden-
tification of Drosophila homologues to components of
vertebrate focal adhesions are likely to refine our working
model.
The Role of mbc in Other Tissues
Although mbc is quite highly expressed in the heart and
the visceral musculature late in development, these tissues
do not appear to be severely affected by the loss of mbc.
The visceral musculature does appear to be somewhat de-
fective, as evidenced by the absence of midgut constric-
tions in a low percentage of embryos, but the heart ap-
pears to be relatively normal. One interpretation of such
behavior is that another gene, yet to be identified, serves a
redundant role in these tissues. Another interpretation is
that, while the level of expression observed in unfertilized
eggs is quite low, adequate maternally derived MBC pro-
tein may be available to embryos lacking zygotic expres-
sion of a functional protein. This may be particularly true
for the pole cells, which express relatively high levels of
MBC early in development.
In summary, we have reported the cloning and charac-
terization of mbc, a novel gene that is essential for events
leading to myoblast fusion and dorsal closure. The striking
conservation of this molecule with DOCK180, a human
gene that may be a target of a signal transduction cascade
activated through focal adhesions, suggests the involve-
ment of a signaling cascade in myogenesis, perhaps
through organization of the actin cytoskeleton. As a more
detailed picture of DOCK180, focal adhesions, and the
family of rho/rac like GTPases is revealed, our under-
standing of the precise role of mbc will grow. Thus, the
further identification of common features and homolo-
gous genes in different developmental systems may allow
us to take advantage of the benefits of each to address the
function of a conserved pathway.
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